The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1-(1-Methylpiperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide dihydrochloride ID: ALA3216789
PubChem CID: 71486406
Max Phase: Preclinical
Molecular Formula: C19H26Cl2N4S
Molecular Weight: 340.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCC(N2CCc3cc(NC(=N)c4cccs4)ccc32)CC1.Cl.Cl
Standard InChI: InChI=1S/C19H24N4S.2ClH/c1-22-9-7-16(8-10-22)23-11-6-14-13-15(4-5-17(14)23)21-19(20)18-3-2-12-24-18;;/h2-5,12-13,16H,6-11H2,1H3,(H2,20,21);2*1H
Standard InChI Key: UJMGPBQWDFAHED-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
6.4838 -0.7375 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6187 1.4919 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6267 2.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9300 3.7369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5905 3.5979 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.0779 5.2168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5472 5.5187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.2884 4.2146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2772 3.1068 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.1852 -2.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6221 -3.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9838 -4.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9039 -5.5373 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4624 -5.1227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1007 -3.6669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1933 -6.7019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9838 -0.7375 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 6 1 0
2 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
13 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 13 1 0
8 19 1 0
19 20 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
22 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 340.50Molecular Weight (Monoisotopic): 340.1722AlogP: 3.64#Rotatable Bonds: 3Polar Surface Area: 42.36Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.78CX LogP: 3.17CX LogD: 1.64Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.66Np Likeness Score: -1.47
References 1. Annedi SC, Maddaford SP, Ramnauth J, Renton P, Rybak T, Silverman S, Rakhit S, Mladenova G, Dove P, Andrews JS, Zhang D, Porreca F.. (2012) Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine., 55 [PMID:22840695 ] [10.1016/j.ejmech.2012.07.006 ]